Physician
Psychiatry
Dr. Manuel E. Tancer, MD
|
|
Give Review
Manuel Tancer works in the field of Psychiatry. He studied medicine at University of Arizona College of Medicine - Tucson. University of Arizona College of Medicine - Tucson is ranked 67 in research and 42 in primary care medicine He over the years received 2 awards: "Super Doctor" and "Top MD". Manuel Tancer is a published physician. He published 85 publications, including: 'A direct-interview family study of generalized social phobia.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Intervention to Reduce Inpatient Psychiatric Admission in a Metropolitan City.
- Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat.
- Evoked potential correlates of Post-Traumatic Stress Disorder in refugees with history of exposure to torture.
- Brain activation patterns in women with acquired hypoactive sexual desire Disorder and women with normal sexual function: a cross-sectional pilot study.
- Escitalopram treatment of menopausal hot flashes.
- What kind of erotic film clips should we use in female sex research? An exploratory study.
- Health issues in the Arab American community. Depression and cardiovascular disease.
- Association between amygdala hyperactivity to harsh faces and severity of social Anxiety in generalized social phobia.
- Neural substrates for voluntary suppression of negative affect: a functional magnetic resonance imaging study.
- Lack of a fluoxetine effect on prednisolone disposition and cortisol suppression.
- Significant difference in beat-to-beat QT interval variability among different leads.
- Electroconvulsive Therapy in Geriatric Patients Undergoing Anticoagulation Therapy.
- ECT in the Treatment of Organic Psychosis in Huntington's Disease.
- ECT and Anticoagulation.
- Metabolic syndrome: relevance to antidepressant treatment.
- Arvid Carlsson, and the story of dopamine.
- Rearing conditions alter social reactivity and D1 dopamine receptors in high- and low-aggressive mice.
- The impact of stress and psychosocial interventions on assisted reproductive technology outcome.
- Over-representation of Myers Briggs Type Indicator introversion in social phobia patients.
- Increased beat-to-beat ''R'' amplitude variability in patients with panic Disorder.
- Increased beat-to-beat QRS amplitude variability in patients with congestive cardiac failure.
- Major depression: the relative contribution of gender, MDMA, and cannabis use.
- Increased pulse-wave velocity in patients with Anxiety: implications for autonomic dysfunction.
- Effects of acute 3,4-methylenedioxymethamphetamine on sleep and daytime sleepiness in MDMA users: a preliminary study.
- Effects of caffeine on heart rate and QT variability during sleep.
- A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social Anxiety disorder.
- Reinforcing effects of diazepam under anxiogenic conditions in individuals with social Anxiety.
- Influence of age on linear and nonlinear measures of autonomic cardiovascular modulation.
- Decreased coherence in higher frequency ranges (beta and gamma) between central and frontal EEG in patients with schizophrenia: A preliminary report.
- Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP.
- Nonlinear measures of respiration: respiratory irregularity and increased chaos of respiration in patients with panic Disorder.
- Linear and nonlinear measures of blood pressure variability: increased chaos of blood pressure time series in patients with panic Disorder.
- Paroxetine decreases respiratory irregularity of linear and nonlinear measures of respiration in patients with panic Disorder. A preliminary report.
- Exaggerated beat-to-beat R amplitude variability in patients with panic Disorder after intravenous isoproterenol.
- Relationship between beat-to-beat variability of RT-peak and RT-end intervals in normal controls, patients with Anxiety, and patients with cardiovascular disease.
- Reduced cardio-respiratory coupling indicates suppression of vagal activity in healthy relatives of patients with schizophrenia.
- Exaggerated differences in pulse wave velocity between left and right sides among patients with Anxiety disorders and cardiovascular disease.
- Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects.
- The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
- Heart rate and QT interval variability: abnormal alpha-2 adrenergic function in patients with panic Disorder.
- Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and plac...
- Influence of olanzapine on QT variability and complexity measures of heart rate in patients with schizophrenia.
- Gastric dysmotility in Major depression.
- Linear and non-linear measures indicate gastric dysmotility in patients suffering from acute schizophrenia.
- Real-time fMRI of cortico-limbic brain activity during emotional processing.
- Cardiac effects of MDMA on the metabolic profile determined with 1H-magnetic resonance spectroscopy in the rat.
- Anterior cingulate neurochemistry in social Anxiety disorder: 1H-MRS at 4 Tesla.
- Neural correlates of internally-generated disgust via autobiographical recall: a functional magnetic resonance imaging investigation.
- Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
- Iron homeostasis in beta-thalassemic mice.
- Sexual dysfunction related to alprazolam treatment of social phobia.
- Use of electroconvulsive therapy at a university hospital: 1970 and 1980-81.
- Major depression in patients with social phobia.
- Impaired effortful cognition in depression.
- Normal serum cholesterol in panic Disorder.
- Behavioral effects of chronic imipramine treatment in genetically nervous pointer dogs.
- Major depression in patients with panic Disorder: factors associated with course and recurrence.
- The hypothalamic-pituitary-thyroid axis in social phobia.
- Paradoxical growth-hormone responses to thyrotropin-releasing hormone in panic Disorder.
- Effects of thyrotropin-releasing hormone on blood pressure and heart rate in phobic and panic patients: a pilot study.
- Growth hormone (GH) response to clonidine and growth hormone releasing factor (GRF) in normal controls.
- Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.
- Phenomenology and neurobiology of social phobia: comparison with panic Disorder.
- An examination of syndromal validity and diagnostic subtypes in social phobia and panic Disorder.
- Evidence for hypothalamo-growth hormone dysfunction in panic Disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH...
- Heart rate and plasma norepinephrine responsivity to orthostatic challenge in Anxiety disorders. Comparison of patients with panic disorder and social phobia and norma...
- Fluoxetine for the treatment of social phobia.
- Short stature, growth hormone deficiency, and social Anxiety.
- Role of serotonin drugs in the treatment of social phobia.
- Evidence for social phobia and other psychiatric Disorders in adults who were growth hormone deficient during childhood.
- Growth hormone response to clonidine and L-dopa in normal volunteers.
- Pharmacological challenge test of the Tridimensional Personality Questionnaire in patients with social phobia and normal volunteers.
- Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia.
- Lactic acid response to caffeine in panic Disorder: comparison with social phobics and normal controls.
- Response to alcohol in social phobia.
- The impact of an electroconvulsive therapy consultation service on ECT use at a university teaching hospital.
- Links between growth hormone deficiency, adaptation and social phobia.
- Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic Disorder.
- Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic Disorder and healthy volunteers.
- Neurobiology of social phobia.
- Normal urinary free cortisol and postdexamethasone cortisol in social phobia: comparison to normal volunteers.
- The subjective effects of MDMA and mCPP in moderate MDMA users.
- Cognitive impairment and depression predict mortality in medically ill older adults.
- A direct-interview family study of generalized social phobia.
Schools
University Of Arizona College Of Medicine
National Institute Mental Health
University Ariz Affil Hosps
University Nc
Conditions Treated
- Anxiety
- Bipolar Disorder
- Major Depressive Disorder
- Obsessive-Compulsive Disorder (OCD)
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- Super Doctor
- Top MD
Education
-
National Institutes of Health Clinical Center -
University of North Carolina Hospitals -
University of Arizona -
University of Arizona College of Medicine - Tucson
Hospital
-
DMC - Detroit Receiving Hospital
Drug Facts
| NPI NUMBER | 1578500062 | |
| NPPES Provider LastName | TANCER | |
| NPPES Provider FirstName | MANUEL | |
| NPPES Provider ZIPCode | 48207 | |
| NPPES Provider State | MI | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 1820.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1578500062 |
| Last Name Of The Provider | TANCER |
| First Name Of The Provider | MANUEL |
| View All |
Similar Doctors
|
|
Dr. Oladayo D. Shobola, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Usha R. Kilaru, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William Martin, MD |
|
|
Dr. Lori D. Holland, DO |
|
|
Dr. Gerhardt A. Hein, MD |
|
|
Dr. Lamis Jabri, MD |
|
|
Dr. Michael R. Bronzo, MD |
|
|
Dr. Pawel A. Galecki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deepak Prabhakar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Alisa D. Smith, FNP |